{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:06:10Z","timestamp":1790060770476,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2020147"],"award-info":[{"award-number":["2020147"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000873","name":"Andrew W. Mellon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL146841"],"award-info":[{"award-number":["K23HL146841"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL156620-01"],"award-info":[{"award-number":["U01 HL156620-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jpain.2023.09.014","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:26:59Z","timestamp":1695385619000},"page":"632-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["\u201cBuprenorphine, It Works so Differently\u201d: Adults with Sickle Cell Disease Describe Transitioning to Buprenorphine for Treatment of Chronic Pain"],"prefix":"10.1016","volume":"25","author":[{"given":"Elizabeth","family":"Prince","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Loeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macy","family":"Early","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-916X","authenticated-orcid":false,"given":"C. Patrick","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lanzkron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia H.","family":"Pecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpain.2023.09.014_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pds.4291","article-title":"Characterization of opioid use in sickle cell disease","volume":"27","author":"Han","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.jpain.2023.09.014_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/pm\/pnac187","article-title":"The complex association of daily opioid dose with visits for pain in sickle cell disease: Tolerance or treatment-refractory pain?","volume":"24","author":"Prince","year":"2023","journal-title":"Pain Med"},{"issue":"1 Suppl 1","key":"10.1016\/j.jpain.2023.09.014_bib4","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic opioid therapy and central sensitization in sickle cell disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am J Prev Med"},{"issue":"10","key":"10.1016\/j.jpain.2023.09.014_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/10245332.2018.1479997","article-title":"Predictive factors of daily opioid use and quality of life in adults with sickle cell disease","volume":"23","author":"Karafin","year":"2018","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.jpain.2023.09.014_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/082585970502100403","article-title":"Physicians' attitude and practices in sickle cell disease pain management","volume":"21","author":"Labbe","year":"2005","journal-title":"J Palliat Care"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4410","article-title":"Management of chronic pain in adults living with sickle cell disease in the era of the opioid epidemic: A qualitative study","volume":"2","author":"Sinha","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/13548506.2021.2019808","article-title":"Stigma and quality of life in adults with sickle cell disease in Jamaica and the United States","volume":"28","author":"Bulgin","year":"2023","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.jpain.2023.09.014_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2018-99-111435","article-title":"Assessing the safety and efficacy of converting adults with sickle cell disease from full agonist opioids to buprenorphine","volume":"132","author":"David","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jpain.2023.09.014_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/ajh.26699","article-title":"Converting adults with sickle cell disease from full agonist opioids to buprenorphine: A reliable method with safety and early evidence of reduced acute care utilization","volume":"97","author":"David","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jpain.2023.09.014_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28766","article-title":"Ambulatory microdose induction of buprenorphine-naloxone in two adolescent patients with sickle cell disease","volume":"68","author":"Buchheit","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jpainsymman.2021.04.007","article-title":"Buprenorphine for chronic pain in a pediatric patient with sickle-cell disease","volume":"62","author":"Irwin","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11606-021-07295-2","article-title":"Transition from oxycodone to buprenorphine\/naloxone in a hospitalized patient with sickle cell disease: A case report","volume":"37","author":"Leyde","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2023.09.014_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2019-126589","article-title":"Use of buprenorphine\/naloxone in ameliorating acute care utilization and chronic opioid use in adults with sickle cell disease","volume":"134","author":"Osunkwo","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/ALN.0000000000000170","article-title":"Buprenorphine-naloxone therapy in pain management","volume":"120","author":"Chen","year":"2014","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.jpain.2023.09.014_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/jpet.113.209478","article-title":"A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine","volume":"348","author":"Tompkins","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/j.pain.0000000000002462","article-title":"Effects of opioid rotation to buprenorphine\/naloxone on pain, pain thresholds, pain tolerance, and quality of life in patients with chronic pain and opioid use disorder","volume":"163","author":"Veldman","year":"2022","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.jpain.2023.09.014_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7326\/M20-7171","article-title":"Treatment of acute pain in adults with sickle cell disease in an infusion center versus the emergency department: A multicenter prospective cohort study","volume":"174","author":"Lanzkron","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2023.09.014_bib19","doi-asserted-by":"crossref","unstructured":"Booth A., Hannes K., Harden A., Noyes J., Harris J., Tong A., COREQ (Consolidated Criteria for Reporting Qualitative Studies), in Guidelines for Reporting Health Research: A User's Manual. 2014. p. 214\u2013226.","DOI":"10.1002\/9781118715598.ch21"},{"key":"10.1016\/j.jpain.2023.09.014_bib20","unstructured":"NVivo. 2020, QSR International Pty Ltd."},{"issue":"2","key":"10.1016\/j.jpain.2023.09.014_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"6","key":"10.1016\/j.jpain.2023.09.014_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.hoc.2022.06.010","article-title":"Quality of life in sickle cell disease: What matters","volume":"36","author":"Treadwell","year":"2022","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"10.1016\/j.jpain.2023.09.014_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5055\/jom.2015.0273","article-title":"Daily home opioid use in adults with sickle cell disease: The PiSCES project","volume":"11","author":"Smith","year":"2015","journal-title":"J Opioid Manag"},{"issue":"1","key":"10.1016\/j.jpain.2023.09.014_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/pmt.15.56","article-title":"Social pain and physical pain: Shared paths to resilience","volume":"6","author":"Sturgeon","year":"2016","journal-title":"Pain Manag"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11606-010-1605-5","article-title":"A video-intervention to improve clinician attitudes toward patients with sickle cell disease: The results of a randomized experiment","volume":"26","author":"Haywood","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/1359105314539530","article-title":"The measure of sickle cell stigma: Initial findings from the improving patient outcomes through respect and trust study","volume":"21","author":"Bediako","year":"2016","journal-title":"J Health Psychol"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11606-017-4289-2","article-title":"Do words matter? Stigmatizing language and the transmission of bias in the medical record","volume":"33","author":"A","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.jpain.2023.09.014_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/CNQ.0000000000000350","article-title":"Patient perspectives of sickle cell management in the emergency department","volume":"44","author":"Crego","year":"2021","journal-title":"Crit Care Nurs Q"},{"issue":"4\u20135","key":"10.1016\/j.jpain.2023.09.014_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/13557858.2011.555520","article-title":"Respect, trust, and the management of sickle cell disease pain in hospital: Comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice","volume":"16","author":"Elander","year":"2011","journal-title":"Ethn Health"},{"issue":"7","key":"10.1016\/j.jpain.2023.09.014_bib30","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jpain.2023.02.022","article-title":"Patient and family opioid decision-making for pain management in sickle cell disease: A qualitative study","volume":"24","author":"Phillips","year":"2023","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.09.014_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107681","article-title":"Epistemic justice is the basis of shared decision making","volume":"111","author":"Galasinski","year":"2023","journal-title":"Patient Educ Couns"},{"issue":"3","key":"10.1016\/j.jpain.2023.09.014_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265342","article-title":"Perspectives of individuals with sickle cell disease on barriers to care","volume":"17","author":"Phillips","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jpain.2023.09.014_bib33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7326\/M20-7418","article-title":"Kneeling was the first step for sickle cell disease","volume":"174","author":"Desai","year":"2021","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.jpain.2023.09.014_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.14423\/SMJ.0000000000000526","article-title":"Examination of the patient and hospitalization characteristics of 30-day SCD readmissions","volume":"109","author":"Carroll","year":"2016","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.jpain.2023.09.014_bib35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","article-title":"Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive \"switching\" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"75","author":"Charache","year":"1996","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.jpain.2023.09.014_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.jpain.2023.09.014_bib37","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.jpain.2023.09.014_bib38","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1526-4637.2011.01276.x","article-title":"Longitudinal observation of changes in pain sensitivity during opioid tapering in patients with chronic low-back pain","volume":"12","author":"Wang","year":"2011","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.jpain.2023.09.014_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40122-021-00348-8","article-title":"Opioid taper is associated with improved experimental pain tolerance in patients with chronic pain: An observational study","volume":"11","author":"Compton","year":"2022","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.jpain.2023.09.014_bib40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2218","article-title":"Improving care for sickle cell pain crisis using a multidisciplinary approach","volume":"143","author":"Balsamo","year":"2019","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.jpain.2023.09.014_bib41","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2009.723","article-title":"Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: A randomized controlled trial","volume":"301","author":"Kroenke","year":"2009","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jpain.2023.09.014_bib42","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pbc.25024","article-title":"Impact of individualized pain plan on the emergency management of children with sickle cell disease","volume":"61","author":"Krishnamurti","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.jpain.2023.09.014_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27274","article-title":"A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department","volume":"65","author":"Schefft","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.jpain.2023.09.014_bib44","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: Defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jpain.2023.09.014_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29961","article-title":"Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center","volume":"70","author":"Hulbert","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.jpain.2023.09.014_bib46","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1089\/tmj.2022.0387","article-title":"Accessible care with high patient satisfaction: Telemedicine use in sickle cell disease","volume":"29","author":"Zhang","year":"2023","journal-title":"Telemed J E Health"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590023005424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590023005424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:13:10Z","timestamp":1761509590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590023005424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1526590023005424"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2023.09.014","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cBuprenorphine, It Works so Differently\u201d: Adults with Sickle Cell Disease Describe Transitioning to Buprenorphine for Treatment of Chronic Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2023.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}]}}